The postdischarge risk of venous thromboembolism after hip replacement. The role of prolonged prophylaxis
- PMID: 9042561
- DOI: 10.2165/00003495-199600527-00010
The postdischarge risk of venous thromboembolism after hip replacement. The role of prolonged prophylaxis
Abstract
This review deals with the problems of delayed thrombosis after hip arthroplasty and the possible need for prolonged prophylaxis. These problems have been considered key questions in the European Consensus Statement on venous thromboembolism. There are several factors, such as long immobilisation, venous trauma and decreased venous emptying, which all may contribute to the development of late postoperative thrombosis. There are data on frequencies of venous thromboembolism supporting the occurrence of such late complications. In 4 recent studies on prolonged prophylaxis, it was consistently shown that prophylaxis with low molecular weight heparins for 1 month significantly reduced the frequency of deep venous thrombosis compared with conventional prophylaxis during hospitalisation in patients undergoing elective hip arthroplasty.
Similar articles
-
A fixed-dose combination of low molecular weight heparin with dihydroergotamine versus adjusted-dose unfractionated heparin in the prevention of deep-vein thrombosis after total hip replacement.Thromb Haemost. 1996 Feb;75(2):246-50. Thromb Haemost. 1996. PMID: 8815569 Clinical Trial.
-
[Heparin-induced thrombocytopenia after elective hip joint replacement with postoperative prevention of thromboembolism with low-molecular-weight heparin].Z Orthop Ihre Grenzgeb. 1999 Nov-Dec;137(6):536-9. doi: 10.1055/s-2008-1039385. Z Orthop Ihre Grenzgeb. 1999. PMID: 10666863 German.
-
Prevention of major venous thromboembolism following total hip or knee replacement: a randomized comparison of low-molecular-weight heparin with unfractionated heparin (ECHOS Trial).Int Angiol. 2006 Dec;25(4):335-42. Int Angiol. 2006. PMID: 17164738 Clinical Trial.
-
The role of low molecular weight heparin in total knee arthroplasty.Am J Knee Surg. 1999 Winter;12(1):55-60. Am J Knee Surg. 1999. PMID: 10050695 Review.
-
Extended-duration low-molecular-weight heparin prophylaxis following total joint arthroplasty.Am J Orthop (Belle Mead NJ). 2002 Sep;31(9 Suppl):31-6. Am J Orthop (Belle Mead NJ). 2002. PMID: 12349893 Review.
Cited by
-
Risk of post-discharge venous thromboembolism in patients with rheumatoid arthritis undergoing knee or hip arthroplasty. Is prolonged thromboprophylaxis warranted or dangerous?Ann Rheum Dis. 1999 Jul;58(7):392-5. doi: 10.1136/ard.58.7.392. Ann Rheum Dis. 1999. PMID: 10381480 Free PMC article. Review. No abstract available.
-
High Risk of Venous Thromboembolism After Surgery for Long Bone Metastases: A Retrospective Study of 682 Patients.Clin Orthop Relat Res. 2018 Oct;476(10):2052-2061. doi: 10.1097/CORR.0000000000000463. Clin Orthop Relat Res. 2018. PMID: 30179923 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical